PK modeling in BE [NCA / SHAM]

posted by mittyri – Russia, 2020-07-19 00:24 (457 d 17:00 ago) – Posting: # 21744
Views: 1,975

Hi Helmut,

» However, last year at the 10th American Conference on Pharmacometrics (20–23 October, Orlando) she gave a presentation “Evaluation of Model Based BioEquivalence (MBBE) statistical approaches for sparse designs PK studies” with a whoopy mean (!) Type I Error of 7.6%. :-(

Are you referring to this one?
Stan approach is a bit better, but still questionable

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,742 posts in 4,546 threads, 1,543 registered users;
online 9 (0 registered, 9 guests [including 6 identified bots]).
Forum time: Tuesday 17:24 CEST (Europe/Vienna)

Sometimes the key to an answer is found
in the way you formulate the question.    David Brin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5